Johnson & Johnson Revenue Growth: 3.91%
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
None selected
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
JNJ Revenue Growth Rankings
| Overall | 39th percentile | 2667 of 4424 |
| Sector | 38th percentile | 287 of 464 in Healthcare |
| Industry | 35th percentile | 13 of 20 in Drug Manufacturers - Major |
JNJ Revenue Growth Range, Past 5 Years
| Minimum | -17.75% | Mar 1994 |
| Maximum | 53.55% | Mar 1995 |
| Average | 10.77% |
About Revenue Growth
Revenue growth illustrates sales increases/decreases over time. It is used to measure how fast a business is expanding. More valuable than a snapshot of revenue, revenue growth helps investors identify trends in order to gauge revenue growth over time.
If a company generated $75 billion in revenue during 2008 and $100 billion in revenue during 2009, the company experienced roughly a ($100 billion/$75 billion)-1 = %33 increase in revenue.
Learn More
You may also be interested in these JNJ related companies
JNJ News
News related to $JNJ, currently-0.6 pct.: 'Stryker says President and CEO MacMillan resigned' http://stks.co/2Ko9
about 3 days ago by TradeBot
about 3 days ago by TradeBot
$JNJ ... swing long started this am is starting to work ... next add area is $65.39ish
about 4 days ago by Leaf_West
about 4 days ago by Leaf_West
$JNJ failed a test of resistance, nice little short opportunity here http://chart.ly/taubwgh
about 6 days ago by optionmaster
about 6 days ago by optionmaster
long $JNJ for dvd looking for break above long long resistance in high 60's. now if they can just avoid a bad news release!
about 6 days ago by Fundies
about 6 days ago by Fundies
$JNJ Insider Sale: $29.6M of stock sold by William Weldon (Director Chairman/ceo) on February 1, 2012 http://stks.co/2F43
about 9 days ago by MarketBrief
about 9 days ago by MarketBrief
@taketheplunge $VRTX That makes little sense to me. More likely a $JNJ BO of $VRTX I would think.
about 9 days ago by SCIGUY
about 9 days ago by SCIGUY
R&D in Quebec pharma industry continues to erode $AZN $JNJ $SNY $MRK
about 10 days ago by michaelbabad
about 10 days ago by michaelbabad
$JNJ Strong Trending 66.315 from 12/27/2011 Hold 5 Days 64% Success http://stks.co/2Bxh 9:33EST #tradeideas #investing #stocks
about 11 days ago by TradeIdeas1
about 11 days ago by TradeIdeas1
Morning News: January 31, 2012 | via @EddyElfenbein http://stks.co/2APO $JNJ $AAPL $RIM
about 12 days ago by STNet
about 12 days ago by STNet
I'd say it was pretty clear that McNeil wasn't anywhere near being on the right track. No-brainer move to change the management again. $JNJ
about 13 days ago by bradloncar
about 13 days ago by bradloncar
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| JNJ | 64.60 | -0.29 | -0.45% | 176.41B |
| EQIX | 128.48 | -2.47 | -1.89% | 6.04B |
| XIN | 2.36 | -0.08 | -3.28% | 180.54M |
| OMC | 47.56 | -0.35 | -0.73% | 13.29B |
| AGM | 20.40 | -0.54 | -2.58% | 211.14M |
| BRCD | 5.80 | -0.14 | -2.36% | 2.85B |
| NWK | 0.92 | -0.04 | -4.17% | 28.01M |
| BAGL | 14.05 | -0.56 | -3.83% | 235.90M |
| KFT | 38.58 | -0.06 | -0.16% | 68.14B |
| EDAP | 2.11 | -0.04 | -1.86% | 27.68M |
